Benzinga · Mar 13, 2026
IS
NASDAQ · ISPC
iSpecimen Inc.
Healthcare · Medical - Diagnostics & Research
$2.30
Up+$0.03 (+1.32%)
Updated Aug 14, 2026, 11:28 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.64M
- P/E ratio
- -0.24
- Dividend yield
- 0.00%
- 52-week range
- $0.10 – $7.29
- Volume
- 48.83K
- Avg. volume
- 1.91M
Price performance
ISPC price history
1M range · 21 trading sessions · Daily adjusted prices
ISPC closed at $2.30 after 21 trading sessions, up 4.07% for the selected period.
- Last close
- $2.30
- Period change
- +4.07%
- Period low
- $1.83
- Period high
- $2.32
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $2.31 | $2.36 | $2.2601 | $2.30 | 48.83K |
| Aug 12, 2026 | $2.23 | $2.35 | $2.21 | $2.27 | 48.47K |
| Aug 11, 2026 | $2.25 | $2.33 | $2.2401 | $2.28 | 48.94K |
| Aug 10, 2026 | $2.29 | $2.38 | $2.18 | $2.24 | 67.52K |
| Aug 7, 2026 | $2.09 | $2.30 | $2.09 | $2.22 | 61.85K |
| Aug 6, 2026 | $1.77 | $2.25 | $1.77 | $2.20 | 342.3K |
| Aug 5, 2026 | $2.14 | $2.22 | $1.91 | $1.92 | 59.77K |
| Aug 4, 2026 | $2.01 | $2.20 | $2.00 | $2.15 | 55.38K |
| Aug 3, 2026 | $1.89 | $2.02 | $1.89 | $2.01 | 30.06K |
| Jul 31, 2026 | $1.89 | $1.90 | $1.77 | $1.89 | 35.79K |
| Jul 30, 2026 | $1.92 | $1.93 | $1.83 | $1.83 | 23.12K |
| Jul 29, 2026 | $1.91 | $1.9446 | $1.88 | $1.90 | 22.66K |
| Jul 28, 2026 | $2.03 | $2.03 | $1.805 | $1.89 | 65.44K |
| Jul 27, 2026 | $2.07 | $2.0825 | $1.97 | $2.01 | 53.12K |
| Jul 24, 2026 | $2.21 | $2.21 | $1.93 | $1.97 | 49.95K |
| Jul 23, 2026 | $2.22 | $2.2709 | $2.19 | $2.23 | 25.29K |
| Jul 22, 2026 | $2.22 | $2.28 | $2.21 | $2.25 | 19.3K |
| Jul 21, 2026 | $2.31 | $2.37 | $2.2189 | $2.26 | 38.89K |
| Jul 20, 2026 | $2.18 | $2.35 | $2.09 | $2.32 | 107.33K |
| Jul 17, 2026 | $2.22 | $2.22 | $2.0612 | $2.10 | 54.6K |
| Jul 16, 2026 | $2.26 | $2.26 | $2.15 | $2.21 | 81.39K |
Latest ISPC news
The latest Smart Investors Daily articles mentioning ISPC.
Stock researchCompany · Overview
ISPC research
Overview
Company profile and research snapshot.
Company profile
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 23, 2022 | EF Hutton | Buy | — |
| Jan 4, 2022 | Craig-Hallum | Buy | — |
| Nov 22, 2021 | EF Hutton | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Mar 4, 2026
12 Health Care Stocks Moving In Wednesday's After-Market Session
ChartMill · Feb 19, 2026
Curious about the stocks that are showing activity after the closing bell on Thursday?
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Benzinga · Feb 19, 2026
12 Health Care Stocks Moving In Thursday's After-Market Session
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
